Ankur Dhingra - 13 Dec 2023 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Issuer symbol
SMMT
Transactions as of
13 Dec 2023
Net transactions value
+$44,254
Form type
4
Filing time
13 Dec 2023, 16:49:19 UTC
Previous filing
08 Mar 2023
Next filing
27 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $1,505 +700 +0.3% $2.15 235,258 13 Dec 2023 By Dhingra Family Revocable Trust F1, F2
transaction SMMT Common Stock Purchase $42,749 +19,700 +8.4% $2.17 254,958 13 Dec 2023 By Dhingra Family Revocable Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased these shares in a single transaction on the open market.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.